Contribution: Industrial Research Assistance Program – Contributions to Firms
RNA Technologies & Therapeutics (RNA T&T) inc.
$249,900.00
E!7335 INCANT: Innovative Characterization of Nanoparticle drug delivery systems for next-generation Therapeutics
EF 2025-26 · 2025-10-01
Résumé
This project completes the development of the iLoF system for profiling Lipid Nanoparticles (LNPs) and Extracellular Vesicles (EVs), with the goal of bringing it to market. The frim is contributing by optimizing characterization methods, producing various LNP formulations, and testing the system on site.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Montreal|Montréal, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
714255304
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2028-03-24
Agreement Number
1035119
Agreement Start Date
2025-10-01
Agreement Title
E!7335 INCANT: Innovative Characterization of Nanoparticle drug delivery systems for next-generation Therapeutics
Agreement Title (French)
E!7335 INCANT : Caractérisation innovante des systèmes de délivrance de médicaments à base de nanoparticules pour les thérapies de nouvelle génération
Agreement Type
Contribution
Agreement Value
$249,900.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project completes the development of the iLoF system for profiling Lipid Nanoparticles (LNPs) and Extracellular Vesicles (EVs), with the goal of bringing it to market. The frim is contributing by optimizing characterization methods, producing various LNP formulations, and testing the system on site.
Description (French)
Ce projet achève le développement du système iLoF pour le profilage des nanoparticules lipidiques (LNP) et des vésicules extracellulaires (EV), dans le but de le commercialiser. L’entreprise contribue à ce projet en optimisant les méthodes de caractérisation, en produisant diverses formulations de LNP et en testant le système sur site.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Laurier--Sainte-Marie
Federal Riding (French)
Laurier--Sainte-Marie
Federal Riding Number
24039
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
714255304
Recipient City
Montreal|Montréal
Recipient Country
CA
Recipient Legal Name
RNA Technologies & Therapeutics (RNA T&T) inc.
Recipient Operating Name
ARN Technologies & Thérapeutiques
Recipient Postal Code
H2W 1R7
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2025-2026-Q3-1035119
